Kainic acid-induced lesion of dopaminergic target cells in the striatum: consequences on the dynamics of cerebellar cGMP
- PMID: 211448
- DOI: 10.1007/BF00501370
Kainic acid-induced lesion of dopaminergic target cells in the striatum: consequences on the dynamics of cerebellar cGMP
Abstract
The bilateral intrastriatal injection of kainic acid (2 microgram/caudate) caused a marked decrease in the activity of striatal dopamine-sensitive adenylate cyclase. This probable loss of target cells for dopamine was associated with a parallel decrease of the cGMP level in the cerebellar cortex, which was maximal (80% loss) by 24 h and prevented apomorphine from raising cerebellar cGMP levels. On the contrary harmaline and isoniazid both increased the levels of cerebellar cGMP in kainic-lesioned rats to the same extent as in control rats. The results indicate that dopamine mechanisms in the striatum are involved in the regulation of cerebellar cortex cGMP.
Similar articles
-
Striato-cerebellar pathway controlling cyclic GMP content in the cerebellum: role of dopamine, GABA and enkephalins.Adv Biochem Psychopharmacol. 1978;18:227-44. Adv Biochem Psychopharmacol. 1978. PMID: 206110 Review. No abstract available.
-
Pharmacologically induced changes in the 3':5'-cyclic guanosine monophosphate content of rat cerebellar cortex: difference between apomorphine, haloperidol and harmaline.J Pharmacol Exp Ther. 1977 Jan;200(1):207-15. J Pharmacol Exp Ther. 1977. PMID: 13199
-
Haloperidol increases and apomorphine decreases striatal dopamine metabolism after destruction of striatal dopamine-sensitive adenylate cyclase by kainic acid.Brain Res. 1977 Jul 15;130(2):374-82. doi: 10.1016/0006-8993(77)90286-4. Brain Res. 1977. PMID: 884534 No abstract available.
-
Disappearance of cerebellar cyclic GMP induced by kainic acid.Brain Res. 1978 Oct 6;154(1):203-8. doi: 10.1016/0006-8993(78)91073-9. Brain Res. 1978. PMID: 212160 No abstract available.
-
Different mechanisms mediating the decrease of cerebellar cGMP elicited by haloperidol and diazepam.Adv Biochem Psychopharmacol. 1976;15:325-35. Adv Biochem Psychopharmacol. 1976. PMID: 192052 Review. No abstract available.